Hi value1008
My 2 cents is:
-Liquidity will remain pretty healthy going forward due to forward events.
-Yes, I received some $ from BIAD's IR firm for the article. But I've also purchased shares in the open market (as high as .22) and will continue to do so on pullbacks because I personally believe in the company after having spoken with management during my due diligence.
-I can't speak for anyone else, but I'm here for the long haul myself. Will some flip for a quick profit? Absolutely... and there's nothing wrong with that. Some will flip for a penny. Others will flip for a dime, others will hold for a 6-12 month period or more, some might sell half after a nice gain and hold the rest, etc. Everyone's different.
But the bottom line (in my opinion) is that liquidity will remain healthy overall as there are several positive forward events to come, and I also believe the company will be making more of an effort to put out press releases/keep current and new investors aware of progress, etc. This belief is based on the conversation I had with the CEO, Tom Barr. I expect liquidity will remain decent for some time, and unless you're looking to sell in a week, who cares really about liquidity? I'm here for commercialization (via Sysmex, or some other biotech giant) of the COAG and MIDS systems...and that's not going to happen in a week or two anyway.
